GHO Capital-backed Ardena to acquire the oral solids development and small-scale manufacturing facility in Somerset, NJ from Catalent.

GHO Capital-backed Ardena, a global CDMO, agreed to acquire the oral solids development and small-scale manufacturing facility in Somerset, NJ from Catalent, a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products. Financial terms were not disclosed. The Somerset facility also houses Catalent’s corporate headquarters, which in the near term will remain at the Somerset site during a transition period before shifting to a new location. The new location of the corporate headquarters will be announced at a later date.